US Patent Issued to BIOPREDICTIVE, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS on July 15 for "Method of prognosis and follow up of primary liver cancer" (French Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,360,113, issued on July 15, was assigned to BIOPREDICTIVE (Paris) and ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (Paris).

"Method of prognosis and follow up of primary liver cancer" was invented by Thierry Poynard (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new methods for assessing the risk of a patient, in particular with chronic liver disease, to develop primary liver cancer over time, using functions combining blood biochemical markers."

The patent was filed on Oct. 15, 2018, under Application No. 16/754,164.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...